Last reviewed · How we verify
Matching placebo to Quetiapine XR — Competitive Intelligence Brief
phase 3
Psychiatry
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching placebo to Quetiapine XR (Matching placebo to Quetiapine XR) — Janssen Research & Development, LLC. This is a matching placebo formulation designed to mimic Quetiapine XR (an atypical antipsychotic) for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching placebo to Quetiapine XR TARGET | Matching placebo to Quetiapine XR | Janssen Research & Development, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching placebo to Quetiapine XR CI watch — RSS
- Matching placebo to Quetiapine XR CI watch — Atom
- Matching placebo to Quetiapine XR CI watch — JSON
- Matching placebo to Quetiapine XR alone — RSS
Cite this brief
Drug Landscape (2026). Matching placebo to Quetiapine XR — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-quetiapine-xr. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab